| Altamed Medical And Dental Group-commerce, Goodrich | |
|
972 Goodrich Boulevard Commerce CA 90022-4114 | |
| (323) 622-2449 | |
| Not Available |
| Full Name | Altamed Medical And Dental Group-commerce, Goodrich |
|---|---|
| Speciality | Clinic/Center |
| Location | 972 Goodrich Boulevard, Commerce, California |
| Authorized Official Name and Position | Robert U. Young (VP, PATIENT FINANCIAL SERVICES) |
| Authorized Official Contact | 3236222429 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Altamed Medical And Dental Group-commerce, Goodrich 2040 Camfield Ave Los Angeles CA 90040-1501 Ph: (323) 622-2429 | Altamed Medical And Dental Group-commerce, Goodrich 972 Goodrich Boulevard Commerce CA 90022-4114 Ph: (323) 622-2449 |
| NPI Number | 1770006728 |
|---|---|
| Provider Enumeration Date | 07/21/2017 |
| Last Update Date | 07/21/2017 |
| Medicare PECOS PAC ID | 4284539966 |
|---|---|
| Medicare Enrollment ID | O20180430001307 |
News Archive
AcelRx Pharmaceuticals, Inc. has announced that it has initiated a Phase 2 clinical trial of ARX-02, a proprietary sublingual sufentanil NanoTab product candidate for cancer breakthrough pain control.
Leading healthcare publisher Lippincott Williams & Wilkins today announced the publication of Operative Techniques in Orthopaedic Surgery, a new, four-volume reference that provides start-to-finish guidance for virtually every contemporary orthopaedic surgery technique. LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and pharmacy.
A major new government survey has revealed that Americans have preferred to keep their health insurance same as before despite the motions by President Donald Trump to remove Obama-care policies altogether.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770006728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
AcelRx Pharmaceuticals, Inc. has announced that it has initiated a Phase 2 clinical trial of ARX-02, a proprietary sublingual sufentanil NanoTab product candidate for cancer breakthrough pain control.
Leading healthcare publisher Lippincott Williams & Wilkins today announced the publication of Operative Techniques in Orthopaedic Surgery, a new, four-volume reference that provides start-to-finish guidance for virtually every contemporary orthopaedic surgery technique. LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and pharmacy.
A major new government survey has revealed that Americans have preferred to keep their health insurance same as before despite the motions by President Donald Trump to remove Obama-care policies altogether.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, presented Phase 2 efficacy results for NeuVax in combination with trastuzumab at the American Society of Clinical Oncology (ASCO) annual meeting.
› Verified 3 days ago
B&r Wound Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5800 S Eastern Ave, Ste 500, Commerce, CA 90040 Phone: 760-694-3587 | |
American Current Care Of California, A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3430 Garfield Ave, Commerce, CA 90040 Phone: 323-722-8481 Fax: 323-721-2236 | |
Dan M Kahen, Do Apc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5504 Whittier Blvd, Commerce, CA 90022 Phone: 323-725-0167 Fax: 323-725-6933 | |
Commerce Family Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6001 E Washington Blvd, Commerce, CA 90040 Phone: 562-928-9600 | |
Carebridge Medical Group, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5800 S Eastern Ave Ste 500, Commerce, CA 90040 Phone: 615-436-9060 Fax: 615-235-9725 | |
On Site Physician Services, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6131 Telegraph Road, Commerce, CA 90040 Phone: 323-721-2100 Fax: 815-759-5202 |